Comparing Two sessions per week of resistance with 10 sessions per week of resistance for healthy adult male and female volunteers
Official title: Effects of Exercise Frequency on Muscle Size and Strength in Healthy, Untrained Young Adults
- 2 groups
- One site, in Vancouver
- Recruiting
Interventions
- Behavioural therapy
10 sessions per week of resistance training
Full-body resistance training consisting of 10 sets per week for all major muscle groups with progressive overload in a gym-based setting. Training at an exercise frequency of 10 brief sessions per week (around 8-12 minutes per session).
- Behavioural therapy
Two sessions per week of resistance training
Full-body resistance training consisting of 10 sets per week for all major muscle groups with progressive overload in a gym-based setting. Training at an exercise frequency of two sessions per week (around 45-60 minutes per session).
Canadian Sites (1)
1 of 1 recruiting
- Recruiting
University of British Columbia | Gateway Health Building
Vancouver, British Columbia
Eligibility Criteria
See who this study is looking for18 criteria
The trial’s own eligibility text, word for word from the registry. Only the trial site can say who takes part.
Inclusion
- +Can fluently read and write in English
- +Lives, works, and/or studies at or near the Gateway Health Building (where all study visits will occur)
- +Willing and able to commit to 2 or 10 in-person training sessions per week for 10 continuous weeks, as well as one week of testing before the training period and one week of testing after the training period
- +Has continuous access to smartphone or other device that they can use to access the Technogym app
- +Answers "No" to all questions on the Canadian Society for Exercise Physiology - Get Active Questonnaire (CSEP-GAQ) or has their doctor's approval to participate
Exclusion
- −Allergic to Tegaderm medical tape (used with the activity trackers)
- −Any major uncontrolled cardiovascular, muscular, metabolic, and/or neurological disorders
- −Lung disease, kidney disease, or liver disease
- −Current diagnosis of type 1 diabetes, type 2 diabetes, or cancer
- −Medical conditions that limit their ability to undertake strenuous physical activity
- −Regular use of any medications that may affect muscle physiology or body composition (i.e. benzodiazepines, hormone replacement therapy, ADHD medication, Metformin, Ozempic)
- −Participated in consistent resistance exercise training more than twice per month in the previous 12 months
- −Participated in consistent moderate or vigorous aerobic training more than twice per week in the previous 12 months, or planning to start consistent training in the next few months
- −Significant gain or loss of body mass in the past 6 months (greater than 2 kg)
- −Body Mass Index of less than 18 kg/m2 or over 30 kg/m2
- −Currently taking blood thinners
- −Pregnancy or breastfeeding
- −Current smoker (including but not limited to cigarettes, e-cigarettes, or vaping)
In plain language
Assembled directly from this trial’s registry record. Every sentence traces to a field below — nothing here is generated or interpreted.
What this study is
This study is investigating how something functions in the body, rather than testing a treatment directly.
This study is not organised into the usual phase numbers — that is common for device, behavioural, and diagnostic research.
From the trial registry
Built from these fields:
- designModule.designInfo.primaryPurpose
- designModule.phases
Who receives what
There are 2 groups in this study.
Group A, the comparison group, receives Two sessions per week of resistance training.
Registry label: A: Standard-frequency resistance training
Group B receives 10 sessions per week of resistance training.
Registry label: B: High-frequency resistance training
From the trial registry
Built from these fields:
- armsInterventionsModule.armGroups[].label
- armsInterventionsModule.armGroups[].type
- armsInterventionsModule.armGroups[].interventionNames
How the study is run
Which group you would be placed in is decided by chance, like a coin flip — not by you and not by your doctor.
This study is open-labelOpen-labelEveryone knows which treatment is being given — nothing is hidden.Read more →: everyone knows which treatment is being given, including you and the study team.
From the trial registry
Built from these fields:
- designModule.designInfo.allocation
- designModule.designInfo.maskingInfo.masking
Is there a placebo?
This study does not list a placeboPlaceboA dummy treatment with no active medicine, used for comparison.Read more → group.
One group receives an existing treatment, so the two can be compared.
From the trial registry
Built from these fields:
- armsInterventionsModule.armGroups[].type
- armsInterventionsModule.armGroups[].interventionNames
Who the study is looking for
The study lists an age range of 19 years to 39 years.
The study is open to people of any sex.
The study accepts healthy volunteersHealthy volunteerSomeone without the condition being studied who takes part anyway.Read more → as well as people with the condition.
These are the criteria the study lists. Only the trial siteTrial siteA hospital or clinic where a study is actually run.Read more → can decide whether someone can take part.
From the trial registry
Built from these fields:
- eligibilityModule.minimumAge
- eligibilityModule.maximumAge
- eligibilityModule.sex
- eligibilityModule.healthyVolunteers
How big and how long
The study aims to enrol about 40 people.
The study is currently expected to finish around June 2027.
The main measurement is taken over: From enrolmentEnrolmentThe number of participants a study plans to include, or has included.Read more → (Week 1) to the end of the exercise training phase (Week 12).
From the trial registry
Built from these fields:
- designModule.enrollmentInfo.count
- statusModule.completionDateStruct.date
- outcomesModule.primaryOutcomes[].timeFrame
What the study measures
Change in Total Body Skeletal Muscle Mass Measured using the D3-Creatine Dilution Method — measured over From enrolmentEnrolmentThe number of participants a study plans to include, or has included.Read more → (Week 1) to the end of the exercise training phase (Week 12).
From the trial registry
Built from these fields:
- outcomesModule.primaryOutcomes[].measure
- outcomesModule.primaryOutcomes[].timeFrame
Source: NCT07760597 on ClinicalTrials.gov. The full registry text is further down this page — this summary never replaces it.
Not medical advice. What do these terms mean?
What is being tested — in plain terms
About 10 sessions per week of resistance trainingBehavioural
Full-body resistance training consisting of 10 sets per week for all major muscle groups with progressive overload in a gym-based setting. Training at an exercise frequency of 10 brief sessions per week (around 8-12 minutes per session).
From the trial registry — its own words, unedited.
What a behavioural is here: A programme, therapy, education, or lifestyle approach being studied.
Read the full explanation → · in clinical review
About Two sessions per week of resistance trainingBehavioural
Full-body resistance training consisting of 10 sets per week for all major muscle groups with progressive overload in a gym-based setting. Training at an exercise frequency of two sessions per week (around 45-60 minutes per session).
From the trial registry — its own words, unedited.
What a behavioural is here: A programme, therapy, education, or lifestyle approach being studied.
Read the full explanation → · in clinical review
Common questions
Answered from this trial’s registry record. Where the record doesn’t say, these answers say so rather than filling the gap.
Am I eligible for this trial?
Only the trial siteTrial siteA hospital or clinic where a study is actually run.Read more → can decide whether someone can take part. Concord cannot make that determination, and neither can any tool that has not examined you.
What the study lists: an age range of 19 years to 39 years.
The full inclusionInclusion criteriaThe things you must have or be for a study to consider you.Read more → and exclusion criteriaExclusion criteriaThe things that would prevent someone from taking part.Read more → are published on this page, exactly as the study team wrote them.
The useful next step is to bring this trial to your doctor. Answering a few questions first gives them something concrete to review.
From the trial registry
- eligibilityModule.minimumAge
- eligibilityModule.maximumAge
- eligibilityModule.eligibilityCriteria
Is there a placebo?
This study does not list a placeboPlaceboA dummy treatment with no active medicine, used for comparison.Read more → group.
One group receives an existing treatment so the two can be compared.
From the trial registry
- armsInterventionsModule.armGroups[].type
Would I know which treatment I am getting?
This study is open-labelOpen-labelEveryone knows which treatment is being given — nothing is hidden.Read more →: everyone knows which treatment is being given, including you and the study team.
Which group you would be placed in is decided by chance, like a coin flip — not by you and not by your doctor.
From the trial registry
- designModule.designInfo.maskingInfo.masking
- designModule.designInfo.allocation
Who can join?
The study lists an age range of 19 years to 39 years.
It is open to people of any sex.
It accepts healthy volunteersHealthy volunteerSomeone without the condition being studied who takes part anyway.Read more → as well as people with the condition.
Only the trial siteTrial siteA hospital or clinic where a study is actually run.Read more → can confirm whether a particular person can take part.
From the trial registry
- eligibilityModule.minimumAge
- eligibilityModule.maximumAge
- eligibilityModule.sex
- eligibilityModule.healthyVolunteers
How long would this take?
The study's main measurement is taken over: From enrolmentEnrolmentThe number of participants a study plans to include, or has included.Read more → (Week 1) to the end of the exercise training phase (Week 12).
The study as a whole is currently expected to finish around 2027-06.
How long any one person takes part can differ from the study length. The study team can tell you what the schedule looks like in practice.
From the trial registry
- outcomesModule.primaryOutcomes[].timeFrame
- statusModule.completionDateStruct.date
How many people are taking part?
The study aims to enrol about 40 people.
From the trial registry
- designModule.enrollmentInfo.count
Where is this happening?
This study lists one location: Vancouver, British Columbia, Canada.
Sites can open and close during a study, so confirm with the team before travelling.
From the trial registry
- trial_locations
About This Trial
Resistance training (RT) is important for building and maintaining healthy muscles. An exercise frequency called "exercise snacks" involves short bursts of exercise throughout the day (\~5-15 minutes), but no studies have examined a gym-based RT exercise snack program. The invetigators will randomize 40 participants into one of two groups for 10 weeks: the control group will complete two full-body workouts per week (standard-frequency) and the experimental group will complete 10 mini-workouts per week (high-frequency). Muscle hypertrophy (size) and strength will be measured before and after the exercise program to determine if the participants had the same or different results.
Think this trial might be right for you?
Complete a quick intake form and we will match you with this and other relevant trials based on your medical profile.
See if this trial could fit youThis page is for informational purposes only and does not constitute medical advice. Clinical trial eligibility can only be determined by the trial site after proper screening. Trial information is sourced from ClinicalTrials.gov and may not reflect the most current status. Always consult your healthcare provider before making decisions about clinical trial participation.